Your Friday crash course: Diagnostic biomarkers are in essence, used to determine whether or not a patient has a medical condition. Biomarkers can be molecular, histologic, radiographic and physiological, examples include heart rate, BMI and x-ray findings. Proteomics International Laboratories (ASX: PIQ) is taking molecular biomarkers to a whole new level, utilising proprietary biomarkers to
Read More
Biotech company Imagion Biosystems (ASX: IBX) has secured a major boost in resources having secured Siemens Healthineers (FWB: SHL) as a collaboration partner for their proprietary cancer detecting agent. The collaboration will centre around Imagion’s MagSense™ nanoparticles which are designed to be visible on a MRI scan once they attach to cancer cells. MagSense™ has
Read More
Osteoarthritis sufferers could soon receive effective pain relief and reduced onset from the degenerative disease after Paradigm Biopharmaceuticals (ASX: PAR) reported breakthrough clinical trial results which identified a significant reduction of pain levels from participants using their Zilosul product. The 53-day clinical trial saw testing of the injectable Pentosan-based treatment (iPPS) which demonstrated a conclusive
Read More